Relates to the content and procedure for certification by pharmacists of patients using medical cannabis; allows a pharmacist employed by a registered organization and responsible for supervising the dispensing of medical cannabis within a cannabis dispensing facility to recommend and certify patients upon consultation within such dispensing facility.
A02566 amends New York’s Cannabis Law to change how patients are certified for medical cannabis and to expand who may issue those certifications. The bill revises the certification standards for practitioners, including clarifying that a patient must have a condition, be under care where applicable, and be likely to benefit from medical cannabis. It also updates the contents of certifications, allows practitioners to specify recommended forms, strains, dosage, or limitations, and requires a reasonable effort to consult the prescription monitoring program before certifying a patient.
The bill also changes the rules for registry identification cards by removing the general one-year expiration framework and instead tying expiration to the practitioner’s stated duration, if any, or to other regulatory requirements. It preserves the ability to issue “special certifications” for progressive, degenerative, or urgent conditions, and requires a two-hour training course before a practitioner may certify patients. Most notably, it adds a new provision allowing pharmacists employed by a registered organization and supervising medical cannabis dispensing in a cannabis dispensing facility to act as authorized practitioners for purposes of recommending and certifying patients, after completing the required course and registering with the Office.
If enacted, the bill would amend multiple provisions of the Cannabis Law governing medical cannabis certification, registry cards, and practitioner authority. It would broaden the pool of professionals able to certify patients by including certain pharmacists at registered organizations, while also tightening procedural requirements around training, monitoring-program review, and certification documentation. The bill would affect practitioners, pharmacists, registered organizations, the Office of Cannabis Management, and patients seeking medical cannabis access.
The available context shows no recorded committee debate or votes, so there is no documented opposition or support in the materials provided. Based on the bill text, the measure appears aimed at improving patient access and streamlining certification by using pharmacists already involved in dispensing medical cannabis, while maintaining oversight through training and registry requirements. The overall tone of the proposal is administrative and access-oriented rather than punitive or restrictive.
The main potential point of contention is the expansion of certification authority to pharmacists employed by registered organizations, which may raise questions about scope of practice, oversight, and whether pharmacists should be treated as authorized practitioners for certification purposes. Another possible issue is the bill’s changes to expiration rules for registry cards and the removal of the prior terminal-illness-specific language, which could affect how long patients remain certified and how much discretion practitioners have. Supporters would likely emphasize improved access and convenience; critics may focus on regulatory complexity, professional boundaries, and patient safety safeguards.